Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following Retinal Vein Occlusion: Post Hoc Analysis of Post-Marketing Surveillance Data in the Real-World Setting in Korea

PURPOSE: To supplement established efficacy and safety data, this analysis evaluated the real-world use of dexamethasone (DEX) intravitreal implant 700 µg for retinal vein occlusion (RVO)-related macular edema in an Asian population and baseline factors potentially associated with DEX implant effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Min Seok, Choi, Jasmine, Lee, Hyeong Du, Woo, Se Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407780/
https://www.ncbi.nlm.nih.gov/pubmed/34475750
http://dx.doi.org/10.2147/OPTH.S302014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407780/
https://www.ncbi.nlm.nih.gov/pubmed/34475750
http://dx.doi.org/10.2147/OPTH.S302014

Ejemplares similares